Results per Page:
Fred Hutch researchers optimize a radioimmunotherapy drug, examine how regulatory T cells influence immune memory
Multi-year, multi-million dollar R01 grants awarded to Drs. Roland Walter, Jennifer Lund
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 30, 2026
A new role for CAR T cells in studying the immune system
From the Peterson Lab, Translational Science and Therapeutics Division
Helping T cells find cancers hiding in plain sight
From the Chapuis Lab, Translational Science and Therapeutics Division
Unraveling how immune aging influences health outcomes for survivors of childhood blood cancers
Fred Hutch pediatric immunologist’s R01 will support search for therapeutic targets to stave off cardiovascular disease and other aging-associated conditions
Autoantibodies in schizophrenia – is the immune system attacking the brain?
From the Ring lab, Translational Science and Therapeutics Division
Fred Hutch Cancer Center announces 2026 Evergreen Fund awardees
Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential
Two Fred Hutch postdocs receive prestigious Damon Runyon awards
The early-career scientists will study the biology of acute myeloid leukemia and how certain treatments can make immunocompromised cancer patients more vulnerable to lung infections
Fred Hutch names 8 recipients of the Dr. Eddie Méndez Award
Annual award celebrates early-career scientists’ research in cancer, infectious disease and basic sciences
Oncology Insights with Dr. Petros Grivas - Episode 13
Dr. Jonathan Wright discusses risk factors, early detection and advances in bladder cancer care
Dr. Hans-Peter Kiem receives ASGCT mentorship award
Fred Hutch gene therapy expert views mentorship as a lifelong commitment
Bringing gene therapy to esophageal cancer, one sip at a time
From the Stephan Lab, Translational Science and Therapeutics Division
How targeted radiation reshapes the bone marrow
From the Termini Lab, Translational Science and Therapeutics Division
Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no graft-versus-host-disease in leukemia patients
A phase 2 study published in the Journal of Clinical Oncology shows that a stem cell product called dilanubicel safely enabled umbilical cord blood transplants in 28 patients
Oncology Insights with Dr. Petros Grivas - Episode 12
Dr. Stanley Riddell traces his journey from bone marrow transplantation to CAR T-cell therapies in a new podcast episode
Fred Hutch researchers test privacy-first AI platform for cancer research
After a year of building the infrastructure for its federated learning platform, the Cancer AI Alliance (CAIA) is road-testing eight projects using de-identified clinical data from four comprehensive cancer centers